Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Conditions: Biliary Tract Cancer; Breast Cancer; Cervical Cancer; Colon Cancer; Endometrial Cancer; Esophageal Cancer; Gastric Cancer; GastroEsophageal Cancer; Head and Neck Cancer; Hepatocellular Cancer; Non-small Cell Lung Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Thyroid Cancer Interventions: Drug: MDX2001 Sponsors: ModeX Therapeutics, An OPKO Health Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Cervical Cancer | Colon Cancer | Colorectal Cancer | Endometrial Cancer | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Head and Neck Cancer | Kidney Cancer | Lung Cancer | Non-Small Cell Lung Cancer | Pancreas | Pancreatic Cancer | Prostate Cancer | Rectal Cancers | Research | Study | Thyroid | Thyroid Cancer